Physician profile
Reza Ehsanian
NPI 1376988535
$18,872.83
in general payments reported to CMS, 2019-2025
20 companies · $7,266 in 2025
The $7,266 reported for 2025 was more than what 98% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $503 · 2022: $4,079 · 2023: $2,982 · 2024: $4,042 · 2025: $7,266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $1,441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,849.53 |
| Travel and Lodging | $1,440.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,111.04 | 2022-2025 | Proclaim, Eterna |
| Medtronic, INC. | $5,386.10 | 2022-2025 | Inceptiv, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Nevro Corp. | $2,390.21 | 2021-2024 | Senza |
| Stryker Corporation | $1,214.72 | 2022 | |
| Globus Medical, INC. | $1,077.65 | 2025 | Senza, Nevro, Vyrsa V1 |
| Saluda Medical Americas, INC. | $459.32 | 2023-2025 | Evoke Scs, Evoke |
| Mimedx Group, INC. | $409.69 | 2024 | |
| Boston Scientific Corporation | $376.01 | 2024-2025 | Intracept |
| Bioventus LLC | $269.55 | 2022-2023 | Stimrouter Implantable Kit |
| Stratus Medical, LLC | $243.06 | 2023 | Nimbus |
| Abbvie INC. | $189.29 | 2021-2025 | |
| Nalu Medical, INC. | $136.18 | 2023 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $104.68 | 2021 | |
| Spr Therapeutics, INC | $99.39 | 2023 | Sprint Pns System |
| Curonix LLC | $86.92 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $85.90 | 2023 | Intracept |
| Tonix Medicines, INC. | $84.05 | 2025 | |
| Biocomposites INC | $67.52 | 2025 | Stimulan |
| Sonex Health, INC. | $41.59 | 2021 | |
| Allergan, INC. | $39.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reza Ehsanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.